Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glaukos (GKOS) Long-Term Investments (2017 - 2025)

Glaukos (GKOS) has disclosed Long-Term Investments for 9 consecutive years, with $19.5 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments rose 32.65% to $19.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.5 million through Dec 2025, up 32.65% year-over-year, with the annual reading at $19.5 million for FY2025, 32.65% up from the prior year.
  • Long-Term Investments for Q4 2025 was $19.5 million at Glaukos, up from $18.7 million in the prior quarter.
  • The five-year high for Long-Term Investments was $19.5 million in Q4 2025, with the low at $5.8 million in Q1 2021.
  • Average Long-Term Investments over 5 years is $11.3 million, with a median of $10.4 million recorded in 2023.
  • The sharpest move saw Long-Term Investments skyrocketed 87.1% in 2021, then rose 11.76% in 2022.
  • Over 5 years, Long-Term Investments stood at $7.4 million in 2021, then rose by 13.51% to $8.4 million in 2022, then skyrocketed by 38.1% to $11.6 million in 2023, then grew by 26.72% to $14.7 million in 2024, then soared by 32.65% to $19.5 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $19.5 million, $18.7 million, and $17.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.